$MAIA SEC Filings

Filed On	Filing
07 Oct 2026	424B3
06 Oct 2026	EFFECT
06 Oct 2026	8-K: Regulation FD Disclosure 1. MAIA Biotechnology, Inc. (the “Company”) has prepared a presentation (the “Presentation”) that management intends to use from time to time in presentations about the Company’s operations and performance on or after October 6, 2026, wh...
02 Oct 2026	Form 4: Theagene Jean-Manasse, Director Granted 32,012 Stock Options
02 Oct 2026	Form 4: Smith Stan, Director Granted 38,871 Stock Options
02 Oct 2026	Form 4: Luput Cristian, Director Granted 33,536 Stock Options
02 Oct 2026	Form 4: Louie Ngar Yee, Director Granted 39,634 Stock Options
02 Oct 2026	Form 4: Guerrero Ramiro, Director Granted 32,012 Stock Options
02 Oct 2026	Form 4: Chaouki Steven M, Director Granted 32,774 Stock Options
02 Oct 2026	424B3
25 Sep 2026	S-3
15 Sep 2026	Form 4: Vitoc Vlad, Director Bought 73,000 shares ($100K)
14 Sep 2026	Form 4: Guerrero Ramiro, Director Bought 37,595 shares ($49.5K)
01 Sep 2026	Form 4: Guerrero Ramiro, Director Bought 8,931 shares ($12.4K) · Bought 78,239 shares ($109K) · Bought 46,620 shares ($62.9K)
28 Aug 2026	EFFECT
26 Aug 2026	Form 4: Guerrero Ramiro, Director Bought 1,794 shares ($2.39K)
24 Aug 2026	Form 4: Guerrero Ramiro, Director Bought 11,899 shares ($16.3K)
21 Aug 2026	S-3
14 Aug 2026	SCHEDULE 13G/A
10 Aug 2026	10-Q

Comments